Holen Sie sich die Stockscreener-App
294.62
0.45%
0.735
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$295.36
Offen:
$295.58
24-Stunden-Volumen:
70,779
Relative Volume:
0.07
Marktkapitalisierung:
$20.81B
Einnahmen:
$3.22B
Nettoeinkommen (Verlust:
$542.70M
KGV:
39.39
EPS:
7.4805
Netto-Cashflow:
$458.00M
1W Leistung:
-4.20%
1M Leistung:
+21.03%
6M Leistung:
+6.52%
1J Leistung:
+40.42%
1-Tages-Spanne:
$294.62
$297.95
1-Wochen-Bereich:
$290.41
$316.00
52-Wochen-Spanne:
$202.79
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
294.62 | 20.64B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
450.14 | 165.27B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
146.24 | 42.53B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
43.35 | 37.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
73.25 | 36.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
210.90 | 31.63B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
WST stock jumps on Q1 earnings & sales beat, EPS view up on HVP growth - MSN
West Pharma jumps as packaging components drive strong Q1 beat - MSN
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services Reclaims Momentum with Q1 2026 Earnings Beat - HarianBasis.co
WST | West Pharmaceutical Services, Inc. Insider Trading - Quiver Quantitative
West Pharmaceutical sr. VP Annette Favorite sells $859,753 in shares By Investing.com - Investing.com India
West Pharmaceutical sr. VP Annette Favorite sells $859,753 in shares - Investing.com
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $859K - TradingView
WST chief accounting officer Chad Winters sells $269,399 in stock - Investing.com
West Pharmaceutical (WST) Upgraded to Strong Buy: Here's What You Should Know - Yahoo! Finance Canada
Are You Looking for a Top Momentum Pick? Why West Pharmaceutical Services (WST) is a Great Choice - Yahoo Finance
Best Momentum Stocks to Buy for April 29th - Yahoo Finance
WST Price Today: West Pharmaceutical Services, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
A Look at West Pharmaceutical Services Inc (WST) After 3.3% Decl - GuruFocus
West Pharmaceutical Services Inc (WST) Stock Price, Trades & News - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services : Selecting a Prefillable Syringe System with Confidence Q&A - marketscreener.com
This pharma stock is soaring after earnings. It’s a sneaky GLP-1 play. - MSN
Trends and Strategies in the 2026 Medical Device CMDO Market: Revenue to Exceed $354 Billion by 2033 - GlobeNewswire Inc.
WST Stock Price Prediction 2025-2026 | West Pharmaceutical Services Inc Forecast | 24/7 Wall St. - 24/7 Wall St.
From Slide to Surge: How West Pharmaceutical Services Reclaimed Its Mojo in 2026 - Yahoo Finance
West schedules two investor conference webcasts in May and June - Stock Titan
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Raises Target Price to $315 - Moomoo
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST): Barclays Lowers Price Target - GuruFocus
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
Here's why West Pharmaceutical Services (WST) is a strong growth stock - MSN
Barclays Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $310 - Moomoo
West Pharmaceutical Services (WST) Stock Analysis: Exploring a 14% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
West Pharmaceutical signals 2026 revenue of $3.295B-$3.35B and adjusted EPS of $8.40-$8.75 driven by HVP components momentum - MSN
symbol__ Stock Quote Price and Forecast - CNN
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
West Pharmaceutical Services, Inc. $WST Shares Purchased by Teacher Retirement System of Texas - MarketBeat
HB Wealth Management LLC Sells 3,325 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Portillo's, West Pharmaceutical, and Oracle: Overvalued Stocks After Recent GainsNews and Statistics - IndexBox
West Pharmaceutical announces up to $1B share repurchase program - MSN
West Pharmaceutical Services, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:WST) 2026-04-25 - Seeking Alpha
WST FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class ActionWST - TMX Newsfile
Barclays raises West Pharmaceutical price target on strong demand By Investing.com - Investing.com Nigeria
Research Alert: CFRA Raises Rating On West Pharmaceutical Services, Inc. To Buy From Hold - Moomoo
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Barclays raises West Pharmaceutical price target on strong demand - Investing.com
West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1 - Sahm
Citi Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $400 - Moomoo
West Pharmaceutical Services Q1 2026: $2.13 EPS Tops Estimates — Deep Dive - AlphaStreet
Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating - marketscreener.com
A Quick Look at Today's Ratings for West Pharmaceutical Services(WST.US), With a Forecast Between $285 to $365 - Moomoo
WST Q1 Deep Dive: High-Value Components and Operational Execution Drive Outperformance - Yahoo Finance
Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating - marketscreener.com
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.78%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):